atomoxetine

Generic: atomoxetine

Labeler: teva pharmaceuticals usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name atomoxetine
Generic Name atomoxetine
Labeler teva pharmaceuticals usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

atomoxetine hydrochloride 60 mg/1

Manufacturer
Teva Pharmaceuticals USA, Inc.

Identifiers & Regulatory

Product NDC 0093-3546
Product ID 0093-3546_6b86d06c-1e99-484b-9643-5ed88511f045
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA079022
Listing Expiration 2026-12-31
Marketing Start 2017-05-30

Pharmacologic Class

Classes
norepinephrine reuptake inhibitor [epc] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00933546
Hyphenated Format 0093-3546

Supplemental Identifiers

RxCUI
349591 349592 349593 349594 349595 608139 608143
UPC
0300933546560 0300933542562 0300933543569 0300933548564 0300933545563 0300933547567 0300933544566
UNII
57WVB6I2W0

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atomoxetine (source: ndc)
Generic Name atomoxetine (source: ndc)
Application Number ANDA079022 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (0093-3546-56)
source: ndc

Packages (1)

Ingredients (1)

atomoxetine hydrochloride (60 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6b86d06c-1e99-484b-9643-5ed88511f045", "openfda": {"upc": ["0300933546560", "0300933542562", "0300933543569", "0300933548564", "0300933545563", "0300933547567", "0300933544566"], "unii": ["57WVB6I2W0"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_set_id": ["4953df7b-ccdb-452c-8699-5fd7259609b4"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (0093-3546-56)", "package_ndc": "0093-3546-56", "marketing_start_date": "20170530"}], "brand_name": "Atomoxetine", "product_id": "0093-3546_6b86d06c-1e99-484b-9643-5ed88511f045", "dosage_form": "CAPSULE", "pharm_class": ["Norepinephrine Reuptake Inhibitor [EPC]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0093-3546", "generic_name": "Atomoxetine", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atomoxetine", "active_ingredients": [{"name": "ATOMOXETINE HYDROCHLORIDE", "strength": "60 mg/1"}], "application_number": "ANDA079022", "marketing_category": "ANDA", "marketing_start_date": "20170530", "listing_expiration_date": "20261231"}